Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Celltrion
Pharmaceutical Preparation ManufacturingSouth KoreaKSC: 068270.KS
Last verified 5 months agocelltrion.com
Celltrion, officially known as Celltrion Healthcare Co., Ltd., is a prominent player in the pharmaceutical preparation manufacturing industry, headquartered in South Korea (KR). Founded in 2002, the company has rapidly evolved, establishing itself as a leader in biopharmaceuticals, particularly in the development and production of monoclonal antibodies and biosimilars.
With a strong operational presence in Europe, the Americas, and Asia, Celltrion focuses on innovative therapies for autoimmune diseases, cancer, and infectious diseases. Its core products, including Remsima and Truxima, are distinguished by their high quality and efficacy, setting new standards in patient care. Recognised for its commitment to research and development, Celltrion has achieved significant milestones, including regulatory approvals in multiple regions, solidifying its market position as a trusted provider of advanced therapeutic solutions.
60
DitchCarbon score
+18 vs industry average
Celltrion’s score of 60 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Celltrion?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2027
20202021202220232024202520262027
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Celltrion's reported carbon emissions
Celltrion, a South Korean Pharmaceutical Preparation Manufacturing company, reported its 2024 carbon emissions as follows: Scope 1 emissions were 27,146,000 kg CO2e, Scope 2 (location-based) emissions were 52,028,000 kg CO2e, and Scope 3 emissions totalled 42,426,000 kg CO2e. These Scope 3 emissions included approximately 986,000 kg CO2e from capital goods, 3,500,000 kg CO2e from business travel, 700,000 kg CO2e from employee commute, 3,202,000 kg CO2e from purchased goods and services, 4,464,000 kg CO2e from waste generated in operations, 18,122,000 kg CO2e from upstream transportation and distribution, and 26,939,000 kg CO2e from downstream transportation and distribution.
In 2023, Celltrion's Scope 1 emissions were 22,457,000 kg CO2e, Scope 2 (location-based) emissions were 42,260,000 kg CO2e, and Scope 3 emissions amounted to 28,798,000 kg CO2e. This included 714,000 kg CO2e from capital goods, 2,112,000 kg CO2e from business travel, 618,000 kg CO2e from employee commute, 4,558,000 kg CO2e from purchased goods and services, 3,035,000 kg CO2e from waste generated in operations, 14,287,000 kg CO2e from upstream transportation and distribution, and 16,136,000 kg CO2e from downstream transportation and distribution.
For 2022, Celltrion's Scope 1 emissions were 21,218,000 kg CO2e and Scope 2 (location-based) emissions were 35,299,000 kg CO2e. In 2021, Scope 1 emissions were 19,402,000 kg CO2e and Scope 2 (location-based) emissions were 35,213,000 kg CO2e. In 2020, Scope 1 emissions were 18,297,000 kg CO2e and Scope 2 emissions were 34,305,000 kg CO2e. In 2019, Scope 1 emissions were 16,864,000 kg CO2e and Scope 2 emissions were 31,667,000 kg CO2e.
Celltrion has set several climate commitments. The company aims to reduce its total GHG emissions by 50% by 2030, compared to 2020 levels, and is working towards achieving carbon neutrality by 2050. Specifically, Celltrion has committed to mitigating Scope 1 and 2 emissions by 42% by 2030 and by 100% by 2045, using a 2022 baseline, across its domestic operations including Celltrion Pharm.
Assessing Celltrion as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Celltrion and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Celltrion’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
7 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Celltrion5 months ago
60
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more